Skip to main content

Table 1 Demographic and clinical outcomes characteristics of the patients stratified by CPR start time (NFT)

From: Prognostic effects of cardiopulmonary resuscitation (CPR) start time and the interval between CPR to extracorporeal cardiopulmonary resuscitation (ECPR) on patient outcomes under extracorporeal membrane oxygenation (ECMO): a single-center, retrospective observational study

Variables and outcomes

Total

(n = 48)

CPR start time; (NFT)

P-value

≤ 5 min

(n = 28)

> 5 min

(n = 20)

Age, (years) #

(Mean ± SD)

41.88 ± 11.5

40.39 ± 12.66

43.20 ± 9.83

0.506

Gender, n (%) †

Male

36 (75)

18 (64.3)

18 (90)

0.042*

 

Female

12 (25)

10 (35.7)

2 (10)

 

Nationality, n (%) †

Middle-East/Africa

18 (37.5)

12 (42.9)

6 (30)

0.364

 

Asian/South Asian

30 (62.5)

16 (57.1)

14 (70)

 

Body Mass Index #

(Mean ± SD)

26.52 ± 5.23

26.82 ± 6.06

26.11 ± 3.91

0.650

Severity of disease,

SOFA score

12.21 ± 3.74

12.21 ± 3.45

12.20 ± 4.2

0.990

(Mean ± SD) #

APACHE II score

29.44 ± 7.62

29.54 ± 7.62

29.30 ± 7.82

0.917

Comorbidities †

yes (%)

19 (39.6)

12 (42.9)

7 (35)

0.583

Types of comorbidities †

Prior Ischemic heart disease

6 (12.5)

5 (17.9)

1 (5)

0.191

 

Dyslipidemia

3 (6.3)

3 (10.7)

0

0.189

 

Diabetes

10 (20.8)

4 (14.3)

6 (30)

0.168

 

Hypertension

7 (14.6)

6 (21.4)

1 (5)

0.118

 

Congestive heart failure

1 (2.1)

1 (3.6)

0

0.583

 

Chronic respiratory disease

3 (6.3)

3 (10.7)

0

0.189

Cardiac arrest location †

In hospital (IHCA)

11 (22.9)

11 (39.3)

0

0.001*

 

Out-of-hospital (OHCA)

37 (77.1)

17 (60.7)

20 (100)

 

Bystander-witnessed †

yes (%)

45 (93.8)

27 (96.4)

18 (90)

0.364

Bystander CPR †

yes (%)

47 (97.9)

28 (100)

19 (95)

0.232

Initial shockable rhythm †

yes (%)

16 (33.3)

15 (53.6)

1 (5)

< 0.001*

Collapse-to-ECPR #

(Mean ± SD)

45.81 ± 20.23

40.25 ± 20.60

53.60 ± 17.34

0.023*

CPR-to-ECPR (LF time) #

(Mean ± SD)

39.5 ± 19.63

36.43 ± 20.33

43.80 ± 18.24

0.203

Duration of CPR

< 30 min (%)

16 (33.3)

13 (46.4)

3 (15)

0.023*

 

> 30 min (%)

32 (66.7)

15 (53.6)

17 (85)

 

CPR duration (min) #

(Mean ± SD)

45.08 ± 31.61

34.96 ± 23.63

59.25 ± 36.27

0.007*

Type of ECMO †

Venovenous (VV)

4 (8.3)

1 (3.6)

3 (15)

0.189

 

Venoarterial (VA)

44 (91.7)

27 (96.4)

17 (85)

 

ECPR location †

Emergency department (ED)

33 (68.8)

17 (60.7)

16 (80)

0.134

 

Intensive Care Unit (ICU)

15 (31.3)

11 (39.9)

4 (20)

 

Cause of cardiac arrest †

Ischemic heart disease

21 (43.8)

13 (46.4)

8 (40)

0.863

 

Pulmonary embolism

6 (12.5)

3 (10.7)

3 (15)

 
 

Others

21 (43.8)

12 (42.9)

9 (45)

 

ECMO length of stay ‡

Median (IQR)

1.5 (1–4)

3 (1–5)

1 (1–2)

0.019*

ICU length of stay ‡

Median (IQR)

3 (1-9.75)

7.5 (1.25–20.75)

1 (1–3)

0.002*

Hospital length of stay‡

Median (IQR)

4 (1–12)

8.5 (2-35.75)

1 (1–4)

0.001*

28-day disability status †

No disability survivors

5 (10.4)

5 (17.9)

0

0.001*

 

Disability survivors

9 (18.8)

9 (32.1)

0

 
 

Non-survivors

34 (70.8)

14 (50)

20 (100)

 

28-day neurological status †

Good recovery survivors

9 (18.8)

9 (32.1)

0

0.001*

 

Poor recovery survivors

5 (10.4)

5 (17.9)

0

 
 

Non-survivors

34 (70.8)

14 (50)

20 (100)

 

ECMO Survival †

yes (%)

17 (35.4)

16 (57.1)

1 (5)

< 0.001*

24-h Survival †

yes (%)

31 (64.6)

22 (78.9)

9 (45)

0.017*

28-day Survival †

yes (%)

14 (29.2)

14 (50)

0

< 0.001*

  1. * P < 0.05 considered as significantly, # t-test, † Chi-square test or Fisher exact test, ‡ Mann-Whitney test, Sequential Organ Failure Assessment (SOFA) Score, Acute Physiology and Chronic Health Evaluation (APACHE II), Cardiopulmonary resuscitation (CPR), Extracorporeal cardiopulmonary resuscitation (ECPR), Extracorporeal membrane oxygenation (ECMO), No flow time (NFT).